This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SNMX Senomyx (SNMX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Senomyx Stock (NASDAQ:SNMX) 30 days 90 days 365 days Advanced Chart Get Senomyx alerts:Sign Up Key Stats Today's Range$1.49▼$1.4950-Day Range N/A52-Week Range$0.83▼$1.71VolumeN/AAverage Volume151,720 shsMarket Capitalization$72.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California. Read More Receive SNMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Senomyx and its competitors with MarketBeat's FREE daily newsletter. Email Address SNMX Stock News HeadlinesDisty Technologies DYTMay 18, 2024 | morningstar.comMAKD Securities Ltd Ordinary Shares AKDSLDecember 9, 2023 | morningstar.comMAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scrambling to buy gold coins and bars. But some savvy investors have used a different way to profit from gold bull runs — a special investment with a long history of making 13 times … 21 times … 157 times … even a surprising 1,000 times more than physical gold.August 10 at 2:00 AM | Weiss Ratings (Ad)NZ Automotive Investments Ltd (NZA)July 19, 2023 | investing.comMcKesson Inc. (MCK): Today's Featured Wholesale LaggardMarch 30, 2023 | thestreet.comFact check: Fetal tissue not in your food, drinks, experts sayFebruary 23, 2023 | usatoday.comHow to Get Stock Exposure to Gluten-Free MovementJune 2, 2022 | thestreet.comSenomyx, Inc.(SNMX)January 29, 2022 | fool.comSee More Headlines SNMX Stock Analysis - Frequently Asked Questions How were Senomyx's earnings last quarter? Senomyx, Inc. (NASDAQ:SNMX) released its quarterly earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.01. The specialty chemicals company had revenue of $3.29 million for the quarter. Senomyx had a negative trailing twelve-month return on equity of 15.80% and a negative net margin of 9.11%. What other stocks do shareholders of Senomyx own? Based on aggregate information from My MarketBeat watchlists, some other companies that Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC) and DURECT (DRRX). Company Calendar Last Earnings8/02/2018Today8/10/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:SNMX CIK1123979 Webwww.senomyx.com Phone858-646-8300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.26 million Net Margins-9.11% Pretax MarginN/A Return on Equity-15.80% Return on Assets-10.48% Debt Debt-to-Equity RatioN/A Current Ratio4.35 Quick Ratio3.92 Sales & Book Value Annual Sales$29.32 million Price / Sales2.46 Cash FlowN/A Price / Cash FlowN/A Book Value$0.39 per share Price / Book3.82Miscellaneous Outstanding Shares48,340,000Free FloatN/AMarket Cap$72.03 million OptionableOptionable Beta1.33 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NASDAQ:SNMX) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senomyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senomyx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.